Press release
Antibody Contract Manufacturing Global Market $21.79 Billion at a CAGR of 14.13% By 2027 | Key Players: AbbVie Inc., Lonza Group AG, Catalent Inc., Pierre Fabre Group, Recipharm AB
Antibody Contract Manufacturing Market
The Business Research Company's Antibody Contract Manufacturing Global Market Report 2023 identifies the rising number of clinical trials is expected to propel the growth of the antibody contract manufacturing market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures.
The global antibody contract manufacturing market is expected to grow from $11.18 billion in 2022 to $12.84 billion in 2023 at a compound annual growth rate (CAGR) of 14.82%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The antibody contract manufacturing market is expected to reach $21.79 billion in 2027 at a CAGR of 14.13%.
Download Free Sample of Antibody Contract Manufacturing Market Report
https://www.thebusinessresearchcompany.com/sample_request?id=12665&type=smp
Major players in the antibody contract manufacturing market are AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim Biopharmaceuticals GmbH, Fujifilm Holdings Corporation, Eurofins Scientific SE, Lonza Group AG, Labcorp Drug Development, Catalent Inc., Charles River Laboratories International Inc., Merck KGaA, Samsung Biologics Co. Ltd., Wuxi Biologics Cayman Inc, Pierre Fabre Group, Siegfried Holding AG, Recipharm AB, Emergent BioSolutions Inc., Aenova Group, Cambrex Corporation, Aldevron LLC, Novasep Holding SAS, Synthon, KBI Biopharma Inc., Nitto Avecia Pharma Services Inc., Cytovance Biologics Inc., and AGC Biologics S.p.A.
Technological advancements are a key trend gaining popularity in the antibody contract manufacturing market. Major companies operating in the antibody contract manufacturing market are adopting new technologies to sustain their position in the market.
Read More On The Global Antibody Contract Manufacturing Market Report Here:
https://www.thebusinessresearchcompany.com/report/antibody-contract-manufacturing-global-market-report
The Antibody Contract Manufacturing Market Is Segmented -
• By Product: Monoclonal Antibodies, Polyclonal Antibodies, Other Products
• By Source: Mammalian, Microbial
• Scale Of Operation: Preclinical, Clinical, Commercial
• By End-User: Biopharmaceutical Companies, Research Laboratories, Other End Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Antibody Contract Manufacturing market.
The Business Research Company's "Global Antibody Contract Manufacturing Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Antibody Contract Manufacturing Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12665
The Table Of Content For The Antibody Contract Manufacturing Market Include:
1. Executive Summary
2. Antibody Contract Manufacturing Market Characteristics
3. Antibody Contract Manufacturing Market Trends And Strategies
4. Antibody Contract Manufacturing Market - Macro Economic Scenario
5. Antibody Contract Manufacturing Market Size And Growth
.....
26. Africa Antibody Contract Manufacturing Market
27. Antibody Contract Manufacturing Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Antibody Contract Manufacturing Market
29. Antibody Contract Manufacturing Market Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody Contract Manufacturing Global Market $21.79 Billion at a CAGR of 14.13% By 2027 | Key Players: AbbVie Inc., Lonza Group AG, Catalent Inc., Pierre Fabre Group, Recipharm AB here
News-ID: 3261290 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Antibody
OBP2A Antibody Market Thrives on Technological Innovations in Antibody Productio …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global OBP2A Antibody Market- (By Type (Polyclonal Antibodies, and Monoclonal Antibodies; By Application-(Enzyme Linked Immunosorbent Assay, Immunohistochemistry, & Western Blot)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global OBP2A Antibody Market is valued at US$ 102.9 Mn in 2023, and it is expected to…
Evolving Market Trends In The Antibody Drug Conjugates Industry: Regulation On A …
The Antibody Drug Conjugates Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Antibody Drug Conjugates Market Size During the Forecast Period?
The market size for antibody drug conjugates has experienced rapid expansion in the past few years. It's projected to rise from…
TIGIT Antibody Clinical Trials FDA Approval Market Size Anti TGIT Antibody Sales …
Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028 Report Highlights:
• Anti TIGIT Antibodies In Clinical Trials: > 50 Antibodies
• First Anti TIGIT Antibody To Get Approval Within Next 5 Years
• Global Anti TIGIT Antibodies Clinical Pipeline Insight By Company, Indication and Phase
• Insight On More Than 50 Anti TIGIT Antibodies In Clinical Trials
• Anti TIGIT Antibodies Market Trends by Indication & Country
• Global Anti TIGIT Antibodies Market Dynamics
Download Report:
https://www.kuickresearch.com/report-anti-tigit-antibody-anti-tigit-antibodies-fda-approved-tigit-antibody-tigit-inhibitors-tigit-drugs-approved-tigit-expression-tigit-ligand-tigit-gene
In recent years, the global…
Mammalian Polyclonal IgG Antibody Market, Mammalian Polyclonal IgG Antibody Mark …
"According to the research report, the global inspection machines market was valued at USD 845.21 million in 2022 and is expected to reach USD 1,437.59 million by 2032, to grow at a CAGR of 5.5% during the forecast period."
Request Our Free Sample Report for Inspection Machines Market Insights and Emerging Trends @ https://www.polarismarketresearch.com/industry-analysis/inspection-machines-market/request-for-sample
Report Overview
Polaris Market Research, a leading global market research and consulting company, has recently published its latest report…
Global Combination Antibody Therapy Market 2022: Antibody/Antibody Combination S …
The combination antibody therapy market is expected to experience significant growth in the coming years. Combination antibody therapy involves the use of two or more monoclonal antibodies (mAbs) in combination to treat various diseases, such as cancer, autoimmune disorders, and infectious diseases.
Request For Free Sample Report of "Combination Antibody Therapy Market"@ https://www.persistencemarketresearch.com/samples/11740
Combination antibody therapy has several potential benefits over single-agent therapies, including increased efficacy, improved patient outcomes, and reduced toxicity.…
Global Combination Antibody Therapy Market 2022: Antibody/Antibody Combination S …
Combination antibody therapy involves the use of two or more antibodies to target and treat a specific disease or condition. This type of therapy is often used in cancer treatment, as it can be more effective at targeting and killing cancer cells than single-antibody therapies. Combination antibody therapy can also be used to treat a range of other diseases and conditions, including autoimmune diseases, infectious diseases, and allergic conditions.
Request For…
